Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies, International Business, and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies, including cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business segment covers international activities such as procurement of active pharmaceutical ingredients, sterile and non-sterile drugs, and supply to public and hospital pharmacies through homecare services. The Pharmaceutical Supply segment offers products for oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG was founded in 2015 and is headquartered in Berlin, Germany.